Compare PHAR & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | PRG |
|---|---|---|
| Founded | 1988 | 2020 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2020 | 2020 |
| Metric | PHAR | PRG |
|---|---|---|
| Price | $12.54 | $33.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $38.33 | ★ $50.00 |
| AVG Volume (30 Days) | 10.3K | ★ 437.6K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.89 |
| Revenue | N/A | ★ $2,409,223,000.00 |
| Revenue This Year | $10.04 | $23.77 |
| Revenue Next Year | $2.51 | $7.91 |
| P/E Ratio | $3,041.22 | ★ $37.78 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.54 | $25.80 |
| 52 Week High | $21.34 | $41.14 |
| Indicator | PHAR | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 29.63 | 50.47 |
| Support Level | $11.43 | $32.07 |
| Resistance Level | $17.41 | $34.04 |
| Average True Range (ATR) | 0.49 | 1.22 |
| MACD | -0.25 | -0.32 |
| Stochastic Oscillator | 15.34 | 12.53 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.